These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 19945449)

  • 21. [Local microviscosity of platelet membranes from patients with chronic renal failure on hemodialysis].
    Rud'ko IA; Chebotarev VN; Kubatiev AA
    Patol Fiziol Eksp Ter; 1994; (1):20-2. PubMed ID: 8183585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet surface receptor activation in patients with chronic renal failure on hemodialysis, peritoneal dialysis and those with successful kidney transplantation.
    Ballow A; Gader AM; Huraib S; Al-Husaini K; Mutwalli A; Al-Wakeel J
    Platelets; 2005 Feb; 16(1):19-24. PubMed ID: 15763892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Changes in platelets, coagulation and fibrinolysis in patients with chronic kidney diseases and hemodialysis].
    Terada H
    Nihon Rinsho; 1992 Jan; 50 Suppl():565-72. PubMed ID: 1578739
    [No Abstract]   [Full Text] [Related]  

  • 24. [Pulmonary infarction as a complication of thrombotic changes in an arteriovenous fistula of a patient with terminal renal insufficiency treated with long-term hemodialysis and recombinant human erythropoietin].
    Wanic-Kossowska M; Pietrzak I
    Pol Merkur Lekarski; 1996 Jul; 1(1):47-8. PubMed ID: 9156894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-output cardiac failure secondary to a brachiocephalic arteriovenous hemodialysis fistula: two cases.
    Young PR; Rohr MS; Marterre WF
    Am Surg; 1998 Mar; 64(3):239-41. PubMed ID: 9520814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Difficult vascular access in patients with end-stage renal failure.
    Nikeghbalian S; Bananzadeh A; Yarmohammadi H
    Transplant Proc; 2006 Jun; 38(5):1265-6. PubMed ID: 16797277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. First hemodialysis access selection varies with patient acuity.
    Friedman AL; Walworth C; Meehan C; Wander H; Shemin D; DeSoi W; Kitsen J; Hill C; Lambert C; Mesler D
    Adv Ren Replace Ther; 2000 Oct; 7(4 Suppl 1):S4-10. PubMed ID: 11053581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Arterial hypertension in patients on chronic hemodialysis].
    Zogović J; Mladenović Lj
    Srp Arh Celok Lek; 1996; 124(9-10):246-50. PubMed ID: 9102857
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peritoneal dialysis is the therapy of choice for end-stage renal disease patients with hereditary clotting disorders.
    Bajo MA; del Peso G; Jiménez V; Aguilera A; Villar A; Jiménez C; Selgas R
    Adv Perit Dial; 2000; 16():170-3. PubMed ID: 11045286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
    Nasri H; Baradaran A
    J Ayub Med Coll Abbottabad; 2004; 16(2):3-8. PubMed ID: 15455608
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Conditions and consequences of cardiac alterations in patients with end-stage renal disease on maintenance hemodialysis].
    Zabicka H
    Postepy Hig Med Dosw; 1996; 50(3):277-91. PubMed ID: 8927587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trends in hemodialysis vascular access from the Australia and New Zealand Dialysis and Transplant Registry (ANZDATA) 2000 to 2005.
    Moist LM; Chang SH; Polkinghorne KR; McDonald SP;
    Am J Kidney Dis; 2007 Oct; 50(4):612-21. PubMed ID: 17900461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical protocol. A phase IIb, randomized, multicenter, double-blind study of the efficacy and safety of Trinam (EG004) in stenosis prevention at the graft-vein anastomosis site in dialysis patients.
    Fuster V; Charlton P; Boyd A
    Hum Gene Ther; 2001 Nov; 12(16):2025-7. PubMed ID: 11727735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of hemodialysis on platelet function in end-stage renal disease Egyptian patients using in vitro closure time test (PFA-100 analyzer).
    Mekawy MA; Habashy DM; Abd El-Mohsen WA
    Platelets; 2015; 26(5):443-7. PubMed ID: 24955720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Dynamic observation of the arteriovenous fistula and the blood flow in patients undergoing hemodialysis].
    Li J; Liu H; Zhu XP
    Hunan Yi Ke Da Xue Xue Bao; 2003 Aug; 28(4):433-4. PubMed ID: 14653142
    [No Abstract]   [Full Text] [Related]  

  • 36. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
    Elsharkawy MM; Youssef AM; Zayoon MY
    Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coagulation and fibrinolysis factors in dialysis patients with and without ischemic heart disease.
    Oda H; Ohno M; Ohashi H
    Adv Perit Dial; 2000; 16():152-5. PubMed ID: 11045282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipid abnormalities associated with end-stage renal disease.
    Liu J; Rosner MH
    Semin Dial; 2006; 19(1):32-40. PubMed ID: 16423180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Renal cell carcinoma and acquired cystic disease of the kidneys in patients on long-term hemodialysis].
    Ikeda R; Suzuki K; Tsugawa R
    Hinyokika Kiyo; 1995 Sep; 41(9):709-17. PubMed ID: 7484538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Changes in plasmic and platelet hemostasis in patients with chronic renal failure in hemodialysis].
    Surovikina MS; Samoĭlenko VV; Vlasova EA; Vasilenko IA; Suslov VP
    Urologiia; 2012; (1):25-9. PubMed ID: 22645997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.